Published in Immunol Lett on August 01, 1990
Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect Immun (1997) 1.57
The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med (1992) 1.56
The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology (1993) 1.29
In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci U S A (1991) 1.18
Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells. PLoS One (2011) 1.15
Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS One (2011) 1.12
Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J Exp Med (2000) 1.10
Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar J (2014) 0.95
Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity. Malar J (2011) 0.83
A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens. J Immunol (2016) 0.79
RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III Trial. Front Immunol (2017) 0.75
Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. J Immunol (1977) 4.67
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol (1989) 4.29
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (1989) 4.08
H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature (1987) 3.10
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76
CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol (1991) 2.67
Cleavage of cytochrome c with cyanogen bromide. Biochim Biophys Acta (1970) 2.44
Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun (1986) 2.14
L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur J Immunol (1991) 1.95
Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol (1987) 1.89
Lymphocyte specificity to protein antigens. II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes. J Exp Med (1979) 1.73
The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J Immunol (1986) 1.71
Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood (1996) 1.68
Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol (2000) 1.68
Malaria sporozoite penetration. A new approach by double staining. J Immunol Methods (1988) 1.65
IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem Biophys Res Commun (1990) 1.60
Kinetics of MHC-antigen complex formation on antigen-presenting cells. J Immunol (1988) 1.59
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect Immun (1997) 1.57
EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J (1993) 1.54
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol (2004) 1.51
Experimental models of cerebral malaria. Curr Top Microbiol Immunol (2005) 1.50
H-2Kd-restricted antigenic peptides share a simple binding motif. J Exp Med (1991) 1.50
Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J Immunol (1993) 1.48
Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr (1999) 1.44
Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy. Clin Exp Allergy (1997) 1.44
Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur J Immunol (1992) 1.42
Survival of rodent malaria merozoites in the lymphatic network: potential role in chronicity of the infection. Parasite (1999) 1.42
Reconstitution of horse heart cytochrome c: reformation of the peptide bond linking residues 65 and 66. Biochem Biophys Res Commun (1974) 1.41
Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol (1989) 1.41
Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate). J Infect Dis (1977) 1.40
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol (1992) 1.40
Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA. J Exp Med (1988) 1.36
A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol (1990) 1.35
Enhanced gametocyte formation by Plasmodium chabaudi in immature erythrocytes: pattern of production, sequestration, and infectivity to mosquitoes. J Parasitol (1996) 1.34
Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. J Immunol (1996) 1.34
Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice. J Immunol (1986) 1.33
Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature (1984) 1.33
Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol (2008) 1.30
Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.30
Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem (1994) 1.29
Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J (1991) 1.27
The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol (1993) 1.27
Competitor analogs for defined T cell antigens: peptides incorporating a putative binding motif and polyproline or polyglycine spacers. Cell (1990) 1.25
Reconstitution of horse heart cytochrome c: interaction of the components obtained upon cleavage of the peptide bond following methionine residue 65. Proc Natl Acad Sci U S A (1971) 1.25
In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol (1993) 1.24
Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule. J Immunol (1992) 1.24
Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun (1998) 1.22
In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci U S A (1991) 1.18
Peptide immunization in humans: a combined CD8+/CD4+ T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL). Clin Exp Immunol (1996) 1.18
Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol (2011) 1.17
Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today (1994) 1.17
Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol (1997) 1.16
Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. Immunol Lett (1990) 1.16
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides. Int Immunol (1991) 1.16
A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies. Eur J Immunol (2001) 1.15
The role of organic anion transporting polypeptides (OATPs/SLCOs) in the toxicity of different microcystin congeners in vitro: a comparison of primary human hepatocytes and OATP-transfected HEK293 cells. Toxicol Appl Pharmacol (2010) 1.15
Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways. J Immunol (1989) 1.14
Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection. Eur J Immunol (1998) 1.14
Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science (2002) 1.14
Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci U S A (1994) 1.12
Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur J Immunol (1990) 1.12
Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg (1999) 1.12
De novo design of fibrils made of short alpha-helical coiled coil peptides. Chem Biol (2001) 1.11
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J Immunol (1995) 1.10
Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Trop Med Int Health (2008) 1.10
Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol (1997) 1.09
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Infect Immun (1997) 1.08
TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. Int Immunol (1991) 1.07
T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J Immunol Methods (1992) 1.06
Inhibitory activity of IL-6 on malaria hepatic stages. Parasite Immunol (1991) 1.06
Macrophage NO2- production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immunol Methods (1991) 1.05
Peptide-primed CD4+ cells and malaria sporozoites. Immunol Lett (1990) 1.05
Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science (1991) 1.05
Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood (1996) 1.04